Nuclear import strategies of high-risk HPV18 L2 minor capsid protein

Virology

Volumn 352, Issue 1, 2006, Pages 200-208

  Klucevsek, K ^a   Daley, J ^a   Darshan, M S ^a   Bordeaux, J ^a   Moroianu, J ^a  

^a BOSTON COLLEGE   (United States)

Author keywords

HPV; Karyopherins; L2 minor capsid protein; Nuclear import

Indexed keywords

CELL NUCLEUS RECEPTOR; HETERODIMER; KAP ALPHA2 ADAPTER RECEPTOR; KAP BETA2 ADAPTER RECEPTOR; KAP BETA3 ADAPTER RECEPTOR; UNCLASSIFIED DRUG; VIRUS CAPSID ANTIGEN; VIRUS DNA; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA BINDING; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 18; NUCLEAR IMPORT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION;

MIRIDAE;

EID: 33746776212     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.04.007     Document Type: Article

References (26)

1. Chen X.S., Garcea R.L., Goldberg I., Casini G., and Harrison S.C. Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol. Cell 5 3 (2000) 557-567
2. Chi N.C., Adam E.J., Visser G.D., and Adam S.A. RanBP1 stabilizes the interaction of Ran with p97 nuclear protein import. J. Cell Biol. 135 3 (1996) 559-569
3. Chook Y.M., and Blobel G. Structure of the nuclear transport complex karyopherin-beta2-Ran × GppNHp. [see comments]. Nature 399 6733 (1999) 230-237
4. Coutavas E., Ren M., Oppenheim J.D., D'Eustachio P., and Rush M.G. Characterization of proteins that interact with the cell-cycle regulatory protein Ran/TC4. Nature 366 6455 (1993) 585-587
5. Darshan M.S., Lucchi J., Harding E., and Moroianu J. The l2 minor capsid protein of human papillomavirus type 16 interacts with a network of nuclear import receptors. J. Virol. 78 22 (2004) 12179-12188
6. Day P.M., Baker C.C., Lowy D.R., and Schiller J.T. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc. Natl. Acad. Sci. U.S.A. 101 39 (2004) 14252-14257
7. Doorbar J., and Gallimore P.H. Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a. J. Virol. 61 9 (1987) 2793-2799
8. Fay A., Yutzy W.H.t., Roden R.B., and Moroianu J. The positively charged termini of L2 minor capsid protein required for bovine papillomavirus infection function separately in nuclear import and DNA binding. J. Virol. 78 24 (2004) 13447-13454
9. Floer M., and Blobel G. The nuclear transport factor karyopherin beta binds stoichiometrically to Ran-GTP and inhibits the Ran GTPase activating protein. J. Biol. Chem. 271 10 (1996) 5313-5316
10. Florin L., Sapp C., Streeck R.E., and Sapp M. Assembly and translocation of papillomavirus capsid proteins. J. Virol. 76 19 (2002) 10009-10014
11. Fried H., and Kutay U. Nucleocytoplasmic transport: taking an inventory. Cell. Mol. Life Sci. 60 8 (2003) 1659-1688
12. Holmgren S.C., Patterson N.A., Ozbun M.A., and Lambert P.F. The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle. J. Virol. 79 7 (2005) 3938-3948
13. Kamper N., Day P.M., Nowak T., Selinka H.C., Florin L., Bolscher J., Hilbig L., Schiller J.T., and Sapp M. A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J. Virol. 80 2 (2006) 759-768
14. Kawana K., Matsumoto K., Yoshikawa H., Taketani Y., Kawana T., Yoshiike K., and Kanda T. A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2. Virology 245 2 (1998) 353-359
15. Lombard I., Vincent-Salomon A., Validire P., Zafrani B., de la Rochefordiere A., Clough K., Favre M., Pouillart P., and Sastre-Garau X. Human papillomavirus genotype as a major determinant of the course of cervical cancer. J. Clin. Oncol. 16 8 (1998) 2613-2619
16. Moroianu J. Nuclear import and export pathways. J. Cell Biochem., Suppl. 32-33 (1999) 76-83
17. Nelson L.M., Rose R.C., and Moroianu J. Nuclear import strategies of high risk HPV16 L1 major capsid protein. J. Biol. Chem. 23 (2002) 23
18. Roden R.B., Kirnbauer R., Jenson A.B., Lowy D.R., and Schiller J.T. Interaction of papillomaviruses with the cell surface. J. Virol. 68 11 (1994) 7260-7266
19. Roden R.B., Greenstone H.L., Kirnbauer R., Booy F.P., Jessie J., Lowy D.R., and Schiller J.T. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype. J. Virol. 70 9 (1996) 5875-5883
20. Roden R.B., Yutzy W.H.t., Fallon R., Inglis S., Lowy D.R., and Schiller J.T. Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes. Virology 270 2 (2000) 254-257
21. Roden R.B., Day P.M., Bronzo B.K., Yutzy W.H.t., Yang Y., Lowy D.R., and Schiller J.T. Positively charged termini of the L2 minor capsid protein are necessary for papillomavirus infection. J. Virol. 75 21 (2001) 10493-10497
22. Weis K., Mattaj I.W., and Lamond A.I. Identification of hSRP1 alpha as a functional receptor for nuclear localization sequences. Science 268 5213 (1995) 1049-1053
23. Yang R., Day P.M., Yutzy W.H.t., Lin K.Y., Hung C.F., and Roden R.B. Cell surface-binding motifs of L2 that facilitate papillomavirus infection. J. Virol. 77 6 (2003) 3531-3541
24. Yang R., Yutzy W.H.t., Viscidi R.P., and Roden R.B. Interaction of L2 with beta-actin directs intracellular transport of papillomavirus and infection. J. Biol. Chem. 278 14 (2003) 12546-12553
25. Yaseen N.R., and Blobel G. Cloning and characterization of human karyopherin beta3. Proc. Natl. Acad. Sci. U.S.A. 94 9 (1997) 4451-4456
26. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 92 9 (2000) 690-698